We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

29 hedge funds and large institutions have $1.33M invested in Histogen Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more call options, than puts

Call options by funds: $24K | Put options by funds: $10K

3% less capital invested

Capital invested by funds: $1.38M → $1.33M (-$46K)

19% less funds holding

Funds holding: 3629 (-7)

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
29
Holders Change
-7
Holders Change %
-19.44%
% of All Funds
0.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
11
Closed
9
Calls
$24K
Puts
$10K
Net Calls
+$14K
Net Calls Change
-$30K

HSTO Hedge Fund Activity: Q3 2019 in Review

29 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2019, worth a combined $1.33M — down 3.3% from $1.38M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of HSTO and 2 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 4 added.

The largest buyer was Acadian Asset Management, adding an estimated $115K. The largest seller was Vanguard Group, cutting an estimated $167K.

  • 29 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2019, down from 36 in Q2 2019.
  • Funds reported $1.33M of Histogen Inc. Common Stock stock for Q3 2019, down 3.3% quarter-over-quarter.
  • 2 funds opened new Histogen Inc. Common Stock positions in Q3 2019 and 9 closed out, a net change of -7 holders.
  • The largest Histogen Inc. Common Stock buyer in Q3 2019 was Acadian Asset Management, an estimated $115K added.
  • The largest Histogen Inc. Common Stock seller in Q3 2019 was Vanguard Group, an estimated $167K sold.

Based on aggregated 13F filings for Q3 2019.